Amyloidosis TTR-Wild Type Patients In New Zealand
TTR amyloidosis is a debilitating disease that if not diagnosed at the early stages, will cause the condition of the sufferers to deteriorate further until the point of death. Listen to two patients from New Zealand share their diagnosis experience, how having the disease has impacted their life and understand that amyloidosis wild type can effect anyone, including you. It is a silent killer. Lets bring awareness and proper education to the masses so correct treatment can be provided. John waited almost 18 years before he got help. Thank you to the patients for freely sharing their experience for the benefit of others. We also thank our supporters Akcea Therapeutics and Eidos Bridgebio for making this awareness video possible.

▶︎
Alan Levi NZAPACONFERENCE2025

▶︎
ARC Talks Webinar: Cardiac and Neurological Approaches in ATTR Management

▶︎
Wild Type ATTR Amyloidosis: Paul’s Story

▶︎
Professional Trainer Alan Levi presentation at New Zealand Amyloidosis Conference

▶︎
The CardioNerds and Dr. Kevin Alexander Discuss ATTR-CM and Transthyretin Instability

▶︎
Treatment Options and Faster Diagnosis of Hereditry ATTR Amyloidosis

▶︎
Medical Stories - Hereditary Amyloidosis (HA) Dylan's Story

▶︎
She Asks if I Know Coldplay and This Singer Shocks The Street

▶︎
14 - Keynote Speaker: TTR Amyloid: How to Find Early and Follow Them Well | UCA 2023

▶︎
An Overview of Wild-Type Amyloidosis (ATTRwt): A World-Renowned Expert and His Patient

▶︎
Transthyretin Amyloid and New Treatment Options

▶︎
James - Wild-Type Amyloidosis Patient

▶︎
Amyloidosis: The Voice of the Patient

▶︎
Unboxing Patisiran/Onpattro for Hereditary Amyloidosis

▶︎
Manifestations in ATTR amyloidosis

▶︎
Wild-Type Transthyretin Cardiac Amyloidosis - Mayo Clinic

▶︎
Leben mit Transthyretin-Amyloidose – Eine Patientin berichtet

▶︎
Nursing and Amyloid

▶︎
Belinda Shares Her AL Amyloidosis Story

▶︎
